Kannapolis, North Carolina Clinical Trials

A listing of Kannapolis, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

The study includes 52 weeks, double-blind treatment period. Clinic visits will occur at Randomization and every four weeks from Week 4 through Week 52 and through End of Study period. The study includes a post-dosing study visit that will occur 4 weeks after the last dose of study drug. This …

diabetes
steatosis
type 2 diabetes mellitus
ballooning degeneration
body mass index
Viking Clinical Site 126
 (6.2 away) Contact site
  • 151 views
  • 30 Jul, 2021
  • +91 other locations
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

The purpose of the study is to evaluate the efficacy of rilematovir compared to placebo treatment with respect to the clinical outcome on the RSV Recovery Scale (RRS).

cough
rsv infection
fever
congestion
rhinorrhea
Jeff Gordon Children's Center
 (10.0 away) Contact site
  • 1 views
  • 04 Aug, 2021
  • +211 other locations
Almond Supplementation and Exercise Recovery

The PURPOSE of this study is to see if eating almonds for four weeks will reduce muscle damage, soreness, and inflammation during several days of recovery from eccentric exercise.

  • 0 views
  • 22 Jul, 2021
  • 1 location
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult patients with active eosinophilic duodenitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab …

Allakos Investigational Site
 (7.1 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +36 other locations
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk …

screening colonoscopy
bowel preparation
Northeast GI Research Division
 (6.2 away) Contact site
  • 561 views
  • 25 Jul, 2021
  • +190 other locations
Comparison of Participants Who Received a CanGaroo Envelope Tyrx Envelope or no Envelope During CIED Implantation

The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo envelope, Tyrx envelope, or no envelope.

Atrium Health
 (10.0 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +10 other locations